Population prevalence and inheritance pattern of recurrent CNVs associated with neurodevelopmental disorders in 12,252 newborns and their parents.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
01 2021
Historique:
received: 08 03 2020
accepted: 21 07 2020
revised: 19 06 2020
pubmed: 12 8 2020
medline: 17 8 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

Recurrent copy number variations (CNVs) are common causes of neurodevelopmental disorders (NDDs) and associated with a range of psychiatric traits. These CNVs occur at defined genomic regions that are particularly prone to recurrent deletions and duplications and often exhibit variable expressivity and incomplete penetrance. Robust estimates of the population prevalence and inheritance pattern of recurrent CNVs associated with neurodevelopmental disorders (NDD CNVs) are lacking. Here we perform array-based CNV calling in 12,252 mother-father-child trios from the Norwegian Mother, Father, and Child Cohort Study (MoBa) and analyse the inheritance pattern of 26 recurrent NDD CNVs in 13 genomic regions. We estimate the total prevalence of recurrent NDD CNVs (duplications and deletions) in live-born children to 0.48% (95% C.I.: 0.37-0.62%), i.e., ~1 in 200 newborns has either a deletion or duplication in these NDDs associated regions. Approximately a third of the newborn recurrent NDD CNVs (34%, N = 20/59) are de novo variants. We provide prevalence estimates and inheritance information for each of the 26 NDD CNVs and find higher prevalence than previously reported for 1q21.1 deletions (~1:2000), 15q11.2 duplications (~1:4000), 15q13.3 microdeletions (~1:2500), 16p11.2 proximal microdeletions (~1:2000) and 17q12 deletions (~1:4000) and lower than previously reported prevalence for the 22q11.2 deletion (~1:12,000). In conclusion, our analysis of an unselected and representative population of newborns and their parents provides a clearer picture of the rate of recurrent microdeletions/duplications implicated in neurodevelopmental delay. These results will provide an important resource for genetic diagnostics and counseling.

Identifiants

pubmed: 32778765
doi: 10.1038/s41431-020-00707-7
pii: 10.1038/s41431-020-00707-7
pmc: PMC7852900
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-215

Références

Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet. 2006;7:85–97.
pubmed: 16418744
Girirajan S, Campbell CD, Eichler EE. Human copy number variation and complex genetic disease. Annu Rev Genet. 2011;45:203–26.
pubmed: 21854229 pmcid: 6662611
Zarrei M, MacDonald JR, Merico D, Scherer SW. A copy number variation map of the human genome. Nat Rev Genet. 2015;16:172–83.
pubmed: 25645873
Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011;43:838.
pubmed: 21841781 pmcid: 3171215
Stankiewicz P, Lupski JR. Genome architecture, rearrangements and genomic disorders. Trends Genet. 2002;18:74–82.
pubmed: 11818139
Weise A, Mrasek K, Klein E, Mulatinho M, Llerena JC, Hardekopf D, et al. Microdeletion and microduplication syndromes. J Histochem Cytochem. 2012;60:346–58.
pubmed: 22396478 pmcid: 3351230
Gudmundsson OO, Walters GB, Ingason A, Johansson S, Zayats T, Athanasiu L, et al. Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder. Transl Psychiatry. 2019;9:258.
pubmed: 31624239 pmcid: 6797719
Levy D, Ronemus M, Yamrom B, Lee Y-H, Leotta A, Kendall J, et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron. 2011;70:886–97.
pubmed: 21658582
Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148:1223–41.
pubmed: 22424231 pmcid: 3351385
Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539–43.
pubmed: 18369103
Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 2008;358:667–75.
pubmed: 18184952
Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genom Hum Genet. 2009;10:451–81.
Guyatt AL, Stergiakouli E, Martin J, Walters J, O’Donovan M, Owen M, et al. Association of copy number variation across the genome with neuropsychiatric traits in the general population. Am J Med Genet B Neuropsychiatr Genet. 2018;177:489–502.
pubmed: 29687944 pmcid: 6099375
Itsara A, Cooper GM, Baker C, Girirajan S, Li J, Absher D, et al. Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet. 2009;84:148–61.
pubmed: 19166990 pmcid: 2668011
Männik K, Mägi R, Macé A, Cole B, Guyatt AL, Shihab HA, et al. Copy number variations and cognitive phenotypes in unselected populations. JAMA. 2015;313:2044–54.
pubmed: 26010633 pmcid: 4684269
Kendall KM, Rees E, Escott-Price V, Einon M, Thomas R, Hewitt J, et al. Cognitive performance among carriers of pathogenic copy number variants: analysis of 152,000 UK biobank subjects. Biol Psychiatry. 2017;82:103–10.
pubmed: 27773354
Magnus P, Birke C, Vejrup K, Haugan A, Alsaker E, Daltveit AK, et al. Cohort profile update: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol. 2016;45:382–8.
Helgeland Ø, Vaudel M, Juliusson PB, Lingaas Holmen O, Juodakis J, Bacelis J, et al. Genome-wide association study reveals dynamic role of genetic variation in infant and early childhood growth. Nat Commun. 2019;10:4448.
pubmed: 31575865 pmcid: 6773698
Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SFA, et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17:1665–74.
doi: 10.1101/gr.6861907
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.
pubmed: 17701901 pmcid: 1950838
Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841–2.
pubmed: 20110278 pmcid: 2832824
Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19:1639–45.
pubmed: 19541911 pmcid: 19541911
Duyzend MH, Nuttle X, Coe BP, Baker C, Nickerson DA, Bernier R, et al. Maternal modifiers and parent-of-origin bias of the autism-associated 16p11.2 CNV. Am J Hum Genet. 2016;98:45–57.
pubmed: 26749307
Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993;52:506–16.
pubmed: 8447318 pmcid: 1682161
Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med. 2011;13:777–84.
pubmed: 21844811 pmcid: 3661946
Rosenfeld JA, Coe BP, Eichler EE, Cuckle H, Shaffer LG. Estimates of penetrance for recurrent pathogenic copy-number variations. Genet Med. 2013;15:478–81.
pubmed: 23258348
Hehir-Kwa JY, Rodríguez-Santiago B, Vissers LE, de Leeuw N, Pfundt R, Buitelaar JK, et al. De novo copy number variants associated with intellectual disability have a paternal origin and age bias. J Med Genet. 2011;48:776–8.
pubmed: 21969336
Delio M, Guo T, McDonald-McGinn DM, Zackai E, Herman S, Kaminetzky M, et al. Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. Am J Hum Genet. 2013;92:439–47.
pubmed: 23453669 pmcid: 3591861
Gillentine MA, Lupo PJ, Stankiewicz P, Schaaf CP. An estimation of the prevalence of genomic disorders using chromosomal microarray data. J Hum Genet. 2018;63:795–801.
pubmed: 29691480 pmcid: 6019170
Hogart A, Wu D, LaSalle JM, Schanen NC. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis. 2010;38:181–91.
pubmed: 18840528
Battaglia A. The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J Rare Dis. 2008;3:30.
pubmed: 19019226 pmcid: 2613132
Sharp AJ, Mefford HC, Li K, Baker C, Skinner C, Stevenson RE, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet. 2008;40:322–8.
pubmed: 18278044 pmcid: 2365467
Lowther C, Costain G, Stavropoulos DJ, Melvin R, Silversides CK, Andrade DM, et al. Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature. Genet Med. 2015;17:149–57.
pubmed: 25077648
Yin J, Chen W, Chao ES, Soriano S, Wang L, Wang W, et al. Otud7a knockout mice recapitulate many neurological features of 15q13.3 microdeletion syndrome. Am J Hum Genet. 2018;102:296–308.
pubmed: 29395075 pmcid: 5985472
Szafranski P, Schaaf CP, Person RE, Gibson IB, Xia Z, Mahadevan S, et al. Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat. 2010;31:840–50.
pubmed: 20506139 pmcid: 3162316
Jacquemont S, Reymond A, Zufferey F, Harewood L, Walters RG, Kutalik Z, et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature. 2011;478:97–102.
pubmed: 21881559 pmcid: 3637175
Hanson E, Bernier R, Porche K, Jackson FI, Goin-Kochel RP, Snyder LG, et al. The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population. Biol Psychiatry. 2015;77:785–93.
pubmed: 25064419
D’Angelo D, Lebon S, Chen Q, Martin-Brevet S, Snyder LG, Hippolyte L, et al. Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities. JAMA Psychiatry. 2016;73:20–30.
pubmed: 26629640 pmcid: 5894477
Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2014;505:361–6.
pubmed: 24352232
Bachmann-Gagescu R, Mefford HC, Cowan C, Glew GM, Hing AV, Wallace S, et al. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet Med. 2010;12:641–7.
pubmed: 20808231
Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41:18–24.
pubmed: 19079260
Bellanne-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, et al. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005;54:3126–32.
pubmed: 16249435
Moreno-De-Luca D, Consortium S, Mulle JG, Simons Simplex Collection Genetics C, Kaminsky EB, Sanders SJ, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet. 2010;87:618–30.
pubmed: 21055719 pmcid: 2978962
Mitchell E, Douglas A, Kjaegaard S, Callewaert B, Vanlander A, Janssens S, et al. Recurrent duplications of 17q12 associated with variable phenotypes. Am J Med Genet Part A. 2015;167A:3038–45.
pubmed: 26420380
Shprintzen RJ. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev. 2008;14:3–10.
pubmed: 18636631 pmcid: 2805186
Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child. 2004;89:148–51.
pubmed: 14736631 pmcid: 1719787
Devriendt K, Fryns JP, Mortier G, van Thienen MN, Keymolen K. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet. 1998;35:789–90.
pubmed: 9733045 pmcid: 1051442
Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol. 2009;23:597–608.
pubmed: 19840297

Auteurs

Dinka Smajlagić (D)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Ksenia Lavrichenko (K)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway.

Siren Berland (S)

Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Øyvind Helgeland (Ø)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Genetics and Bioinformatics, Norwegian Institute of Public Health, Oslo, Norway.

Gun Peggy Knudsen (GP)

Department of Genetics and Bioinformatics, Norwegian Institute of Public Health, Oslo, Norway.

Marc Vaudel (M)

Department of Clinical Science, University of Bergen, Bergen, Norway.

Jan Haavik (J)

Department of Biomedicine, University of Bergen, Bergen, Norway.
Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.

Per Morten Knappskog (PM)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Pål Rasmus Njølstad (PR)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Pediatrics and Adolescents, Haukeland University Hospital, Bergen, 5021, Norway.

Gunnar Houge (G)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Stefan Johansson (S)

Department of Clinical Science, University of Bergen, Bergen, Norway. stefan.johansson@uib.no.
Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway. stefan.johansson@uib.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH